Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.


Product Name:                  (R)-3-Butyn-2-ol

Synonyms:                         N/A

CAS Number:                     42969-65-3

Molecular Weight:            70.0908

Molecular Formula:          C4H6O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               C[C@H](C#C)O

  • $130.00
  • Ex Tax: $130.00

Available Options